Jiong Cai
Overview
Explore the profile of Jiong Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jin X, Zhang Y, Cao X, Wang P, Ren C, Cai J, et al.
Clin Nucl Med
. 2024 Dec;
50(1):25-30.
PMID: 39626289
Purpose: Accuracy in in vivo assessment of human epidermal growth factor receptor type 2 (HER2) status is crucial for predicting the response to HER2-targeted therapies in breast cancer. This study...
2.
Li X, Mei T, Wang P, Cai J, Hu X
Front Med (Lausanne)
. 2024 Sep;
11:1461749.
PMID: 39328318
Myofibroblastic sarcoma (MS) is a relatively rare malignant bone and soft tissue tumor, which originates from myofibroblasts, with some characteristics of both smooth muscle cells and fibroblasts. It can develop...
3.
Hu H, Hu X, Liang Z, Yang W, Li S, Li D, et al.
Oncol Lett
. 2024 Sep;
28(5):546.
PMID: 39319212
Breast cancer remains the leading cause of cancer-related death in women, with 5-year survival rates of as high as 90% for patients with early-stage breast cancer without metastasis, falling to...
4.
Hu X, Hu H, Li D, Wang P, Cai J
Open Med (Wars)
. 2024 Sep;
19(1):20241027.
PMID: 39247440
Purpose: This study aimed to assess the biodistribution and bioactivity of the affibody molecular probe Tc-(HE)Z, prepared by genetic recombination, and to investigate its potential for targeted human epidermal growth...
5.
Hu X, Li X, Wang P, Cai J
Acad Radiol
. 2024 Aug;
32(1):191-200.
PMID: 39097507
Purpose: Fibroblast activating protein is a promising target for tumor molecular imaging and therapy. Studies showed that fibroblast activating protein inhibitor (FAPI) radioactive tracers presented superiority over F-FDG PET/CT in...
6.
Hu X, Zhao W, Li F, Wang P, Cai J
Front Med (Lausanne)
. 2024 Jul;
11:1437597.
PMID: 39081690
Pulmonary mixed squamous cell and glandular papilloma (MSGP) is a rare benign lung tumor with both squamous and glandular epithelial components. Reports on primary lung MSGP are few, and the...
7.
Hu X, Li X, Xiong Z, Li D, Cai J, Wang P
Front Oncol
. 2024 Jul;
14:1296401.
PMID: 38962269
Introduction: Epithelioid hemangioma (EH) is an intermediate locally aggressive tumor that consists of epithelioid cells and endothelial cell differentiation, which can occur at any age, but is most common between...
8.
Hu X, Li X, Zhao W, Cai J, Wang P
Front Med (Lausanne)
. 2024 May;
11:1408967.
PMID: 38818401
Primary clear cell carcinoma of liver (PCCCL) is a special and relatively rare subtype of hepatocellular carcinoma (HCC), which is more common in people over 50 years of age, with...
9.
Li X, Hu X, Wang P, Cai J
Front Med (Lausanne)
. 2024 Apr;
11:1346647.
PMID: 38576707
Schwannomatosis is a rare autosomal dominant hereditary syndrome disease characterized by multiple schwannomas throughout the body, without bilateral vestibular schwannoma or dermal schwannoma. The most common location of schwannomatosis is...
10.
Li X, Hu X, Wang P, Hu G, Zhou B, Cai J
Exp Ther Med
. 2024 Mar;
27(5):186.
PMID: 38533436
Splenosis pertains to the phenomenon wherein a segment of the spleen undergoes detachment and becomes embedded in other anatomical regions subsequent to traumatic rupture or therapeutic resection, and then progressively...